ENERTIVA

RETATRUTIDE 20 mg / 3 mL

Product Information

Product:
Retatrutide
Presentation:
20 mg / 3 mL Multi-Dose Vial
Appearance:
White Lyophilized Powder
Storage:
2–8°C
Lot / Batch:
RETA26-01
CAS No.:
2607140356

Professional Use Only

Retatrutide is an investigational peptide compound currently being studied for its activity across GLP-1, GIP, and glucagon receptor pathways. Purify Meds provides batch-specific quality documentation and analytical testing information to support product traceability and professional evaluation.

Testing & Quality Documentation

Reports are updated in the administration area for each batch. Current documentation applies.

  • HPLC + MS
  • Endotoxin
  • Sterility
  • Batch-Specific COA

Currently Shipping

Lot / Batch:
RETA26-01
Test Date:
07/14/2026
Purity:
99.98%
Assay / Content:
20mg

Disclaimer

For professional use only. This product has not been approved by the U.S. Food and Drug Administration. Product information and analytical documentation are provided for professional evaluation and quality reference purposes only. No representation is made regarding FDA approval, safety, or effectiveness for any particular medical use.